(Q44154680)

30 November 2017

Synthesis of glycosylated beta-amino acids as new class of antitubercular agents (English)

1 reference

30 November 2017

1 reference

R P Tripathi

1

1 reference

30 November 2017

R Tripathi

2

1 reference

30 November 2017

V K Tiwari

3

1 reference

30 November 2017

Laxmi Bala

4

1 reference

30 November 2017

S Sinha

5

1 reference

30 November 2017

A Srivastava

6

1 reference

30 November 2017

R Srivastava

7

1 reference

30 November 2017

B S Srivastava

8

1 reference

30 November 2017

1 September 2002

1 reference

European Journal of Medicinal Chemistry

30 November 2017

1 reference

30 November 2017

37

1 reference

30 November 2017

9

1 reference

30 November 2017

773-781

1 reference

The changing face of tuberculosis

30 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Treatment and developmental therapeutics of Mycobacterium tuberculosis infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Multiple-drug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Permeability of the cell wall of Mycobacterium smegmatis.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

The Envelope of Mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Overexpression of the D-alanine racemase gene confers resistance to D-cycloserine in Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

In vitro activity of fludalanine combined with pentizidone compared with those of other agents

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Inhibition of cell wall biosynthesis by analogues and alanine

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Homologated aza analogs of arabinose as antimycobacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

High-throughput screen for detecting antimycobacterial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Activity of the combination of fludalanine and cycloserine against mycobacteria in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Identification of inhibitors of DNA topoisomerase II from a synthetic library of glycoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Improved brain delivery of AZT using a glycosyl phosphotriester prodrug.

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Antileishmanial drug targeting through glycosylated polymers specifically internalized by macrophage membrane lectins

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Theory and modeling of stereoselective organic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

Determination of minimal inhibitory concentrations of antituberculosis drugs by radiometric and conventional methods

1 reference

https://api.crossref.org/works/10.1016%2FS0223-5234%2802%2901398-3

7 January 2021

10.1016/S0223-5234(02)01398-3

Identifiers

DOI

1 reference

30 November 2017

1 reference